China Universal Asset Management »

Karuna Therapeutics Ord shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Karuna Therapeutics Ord shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Karuna Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Karuna Therapeutics Ord held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karuna Therapeutics Ord by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 4.4k 316.53
2023-09-30 $164k 971 168.90
2023-06-30 $106k 490 216.33
2023-03-31 $85k 468 181.62
2022-12-31 $69k 349 197.71
2022-09-30 $72k 318 226.42

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Karuna Therapeutics Ord

Vanguard Group
T. Rowe Price Associates
Pentwater Capital Management
Wellington Management Company
UBS Group
Alliancebernstein
Norges Bank Investment Management
Balyasny Asset Management
First Light Asset Management
Citadel Advisors
Boxer Capital
Charles Schwab Investment Management
Alpine Associates Management
Avidity Partners Management
Goldman Sachs Group

View all funds holding Karuna Therapeutics Ord